Half-year report · Q2
3645.TEDINET S100V2YB
Period2024-06-01 → 2024-11-30
Filed2025-01-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.9bn | 2024-06-01 → 2024-11-30 | Cons. | Net sales |
| Revenue | ¥5.3bn | 2023-06-01 → 2024-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.3bn | 2023-06-01 → 2023-11-30 | Cons. | Net sales |
| Operating income | ¥48m | 2024-06-01 → 2024-11-30 | Cons. | Operating income |
| Operating income | ¥170m | 2023-06-01 → 2023-11-30 | Cons. | Operating income |
| Ordinary income | ¥67m | 2024-06-01 → 2024-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥323m | 2023-06-01 → 2024-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥194m | 2023-06-01 → 2023-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥59m | 2024-06-01 → 2024-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥192m | 2023-06-01 → 2023-11-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥17m | 2024-06-01 → 2024-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6m | 2023-06-01 → 2024-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥116m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1m | 2024-06-01 → 2024-11-30 | Cons. | Profit loss |
| Net income | ¥126m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss |
| Total assets | ¥4.4bn | at 2024-11-30 | Cons. | Assets |
| Total assets | ¥4.0bn | at 2024-05-31 | Cons. | Assets |
| Total assets | ¥3.6bn | at 2023-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.5bn | at 2024-11-30 | Cons. | Liabilities |
| Total liabilities | ¥2.1bn | at 2024-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.9bn | at 2024-11-30 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2024-05-31 | Cons. | Net assets |
| Net assets / equity | ¥2.0bn | at 2023-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2024-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2024-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2024-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2024-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2023-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2023-05-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥56m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥120m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥131m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥23m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥285m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥14m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥21m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥144m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥14m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-1.89 | 2024-06-01 → 2024-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.66 | 2023-06-01 → 2024-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.8 | 2023-06-01 → 2023-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 42.5% | at 2024-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.8% | at 2024-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.4% | at 2023-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 45
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-06-01 → 2024-11-30 | ¥908,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-06-01 → 2024-11-30 | ¥908,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-06-01 → 2024-11-30 | ¥908,000 |
| jpcrp040300-q2r_E24982-000Cloud Integrationreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥219m |
| jpcrp040300-q2r_E24982-000Cloud Integrationreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥219m |
| jpcrp040300-q2r_E24982-000Cloud Integrationreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥41m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥546m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥546m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥279m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥87m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥87m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2024-06-01 → 2024-11-30 | −¥11m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥2.0bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥2.0bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥83m |
| jpcrp040300-q2r_E24982-000Pre Symptomatic And Preventive Disease Platformreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥19m |
| jpcrp040300-q2r_E24982-000Pre Symptomatic And Preventive Disease Platformreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥19m |
| jpcrp040300-q2r_E24982-000Pre Symptomatic And Preventive Disease Platformreportable segment | segment profit | 2024-06-01 → 2024-11-30 | −¥104m |
| —segment total | revenue | 2024-06-01 → 2024-11-30 | ¥2.9bn |
| —segment total | revenue external | 2024-06-01 → 2024-11-30 | ¥2.9bn |
| —segment total | segment profit | 2024-06-01 → 2024-11-30 | ¥287m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-06-01 → 2024-11-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-06-01 → 2024-11-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-06-01 → 2024-11-30 | ¥288m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-06-01 → 2023-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-06-01 → 2023-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-06-01 → 2023-11-30 | ¥2m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥562m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥562m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥315m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥70m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥70m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥7m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥1.7bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥1.7bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥68m |
| —segment total | revenue | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| —segment total | revenue external | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| —segment total | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| —segment total | segment profit | 2023-06-01 → 2023-11-30 | ¥390m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2023-11-30 | ¥392m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 542
| Item | Context | Value | Unit |
|---|---|---|---|
| Increase decrease in advances received ope cf | Prior1YTDDuration | 2444000 | JPY |
| Increase decrease in advances received ope cf | CurrentYTDDuration | 56986000 | JPY |
| Other net ope cf | Prior1YTDDuration | -3142000 | JPY |
| Other net ope cf | CurrentYTDDuration | 31661000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | -45293000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 9923000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 708000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 1352000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -2170000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -5929000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -84145000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -61035000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | -130900000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | -55688000 | JPY |
| Proceeds from withdrawal of time deposits inv cf | Prior1YTDDuration | － | JPY |
| Proceeds from withdrawal of time deposits inv cf | CurrentYTDDuration | 300000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -12320000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -18853000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | Prior1YTDDuration | 2552000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | CurrentYTDDuration | － | JPY |
| Payments of loans receivable inv cf | Prior1YTDDuration | -3000000 | JPY |
| Payments of loans receivable inv cf | CurrentYTDDuration | － | JPY |
| Collection of loans receivable inv cf | Prior1YTDDuration | 1695000 | JPY |
| Collection of loans receivable inv cf | CurrentYTDDuration | 1712000 | JPY |
| Payments for lease and guarantee deposits inv cf | Prior1YTDDuration | -2200000 | JPY |
| Payments for lease and guarantee deposits inv cf | CurrentYTDDuration | -2055000 | JPY |
| Purchase of insurance funds inv cf | Prior1YTDDuration | -860000 | JPY |
| Purchase of insurance funds inv cf | CurrentYTDDuration | -860000 | JPY |
| Other net inv cf | Prior1YTDDuration | -134000 | JPY |
| Other net inv cf | CurrentYTDDuration | -3665000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -14267000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -23421000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration | 50819000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | 149567000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -14481000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -40116000 | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration | － | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -2456000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -22237000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -26779000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | － | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -15646000 | JPY |
| Decrease increase in deposit paid for repurchase of treasury stock fin cf | Prior1YTDDuration | － | JPY |
| Decrease increase in deposit paid for repurchase of treasury stock fin cf | CurrentYTDDuration | -85281000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | 14100000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -20711000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 12043000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 15317000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -119024000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -84504000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |